ABSTRACT. Fibroblasts from the original sialuria patient are shown to contain high levels of free sialic acid, i.e., an average of 87 versus a normal average of 2 nmollmg of protein. Gas liquid chromatography-mass spectrometry analysis confirmed that the accumulated material is Nacetylneuraminic acid. Addition of D(+) glucosamine (0-5 mM) to the media of these cells increased the intracellular free sialic acid concentrations from 74 to 137 nmollmg protein. In contrast, normal cells treated in an identical manner maintained their normal free sialic acid level of less than 4 nmol/mg protein. Addition of 20 mM Nacetylmannosamine in place of glucosamine resulted in a marked increase in free sialic acid in both the patient and the control, i.e., increases of 157 (from 95 to 252) and 120 (from 3 to 123) nmol/mg protein, respectively. Finally, while normal cells in the presence of glucosamine accumulated high levels of uridine diphosphate N-acetylhexo---
samine, the patient's cells accumulated much lower amounts of this compound. It is concluded that the elevated sialic acid level in sialuria is due, at least in part, to overproduction of free N-acetylneuraminic acid. Indirect evidence is presented that this may result from either hyperactivity or increased levels of the enzyme (uridine diphosphate N-acetylglucosamine 2-epimerase) that has been shown in other tissues to convert uridine diphosphate N-acetylglucosamine to N-acetylmannosamine. (Pediatr Res 19: 451-455,1985) Abbreviations UDP, uridine diphosphate CMP, cytidine monophosphate In a series of papers dating from 1967 to the present, a number of investigators have described a male who excretes massive amounts (> 5 g/day) of N-acetylneuraminic acid (1) (2) (3) . The clinical findings in this unique case include mental retardation, seizures, mildly dysmorphic features, hepatomegaly, and metabolic acidosis (1) (2) (3) . Due to the striking biochemical alteration, the condition was given the designation "sialuria." McKusick (4) lists this disorder (Cat. no. 26990) as a possible, recessively inherited disorder.
Subsequent investigations carried out on urine from this patient revealed, in addition, excessive amounts of a number of potential precursors and/or metabolites of sialic acid (5) (6) (7) (8) . These deoxy-2,3-dehydro-N-acetylneuraminic acid (6) , and 2-acetamidoglucal (5) . We now report that cultured skin fibroblasts from the original sialuria patient exhibit altered sialic acid metabolism and/or storage, i.e. contain elevated levels of N-acetylneuraminic acid.
Evidence is presented that indicates that the increased level of sialic acid in these cells is due, at least in part, to overproduction of N-acetylneuraminic acid. Specifically, these data suggest that the excessive level of sialic acid could result from hyperactivity or increased levels of UDP-acetylglucosamine Zepimerase responsible for the conversion of UDP-N-acetylglucosamine to Nacetylmannosamine. It is speculated that the proposed increased epimerase activity could result from a lack of normal feedback inhibition of this enzyme.
MATERIALS AND METHODS
Fibroblasts from the original and only known sialuria patient were kindly provided to us by Professor J. P. Farriaux, Centre Hospitalier Regional de Lille, Lille, France. Both these and the control cells were held in liquid nitrogen until needed, at which time they were recultured (9-1 1). As the only sialuria cell line available to us is infected with mycoplasma, control studies were carried out on normal cell lines both with and without infection with the same strain of mycoplasma. In all studies reported herein no detectable differences were found in these control cells and the normal data were combined.
Once reestablished, the cultures were maintained in Eagle's Minimum Essential Medium with Earles' salts (GIBCO Laboratories, Grand Island, NY) supplemented with fetal calf serum (final concentration 13%), penicillin (final concentration 85 U/ ml), streptomycin (final concentration 85 pg/ml), and L-glutamine (final concentration 1.7 pmol/ml).
For the loading tests the cells were subcultured into 490 cm2 roller bottles and incubated in the maintenance medium (see above) until just confluent, i.e. 3-4 days. At this time the medium was aspirated from the cells and replaced with the following: Eagle's Minimum Essential Medium with Earles' salts supplemented with heat inactivated, dialyzed fetal calf serum (final concentration 10%) and L-glutamine (final concentration 2.0 pmol/ml). For the loading studies the fetal calf serum was heat inactivated (52" C for 30 min with shaking) and dialyzed (overnight against 2 liters of deionized water in the cold with one change after 2 h). Glucosamine or N-acetylmannosamine was dissolved in this medium to the final concentrations given in "Results."
Following incubation the cells were harvested, washed, and sonicated as previously described ( 12) . Where indicated, the cell sonicates were precipitated with 10% trichloroacetic acid, centrifuged, the supernatant extracted with ethyl ether, and then neutralized with NH40H as described elsewhere (1 2). UDP-N-acetylhexosamines and sialic acid was isolated from the neutralized trichloroacetic acid soluble fraction by ion ex- 
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stepwise gradient of formic acid and/or NH4 formate according to a modification (12) of the method of Akamatsu et al. (14) .
Detection and/or quantitation of the UDP-N-acetylhexosamines was based on absorbance at 262 mp. The thiobarbituric acid-reactive material was measured according to a micromethod (1 5) of the Warren procedure (1 6). Gas liquid-mass spectrometry analysis of the isolated material was camed out as previously described (12) . CMP-sialic acid was determined in cell sonicates after destruction of the existing free sialic acid with 2.7 M sodium borohydride in 0.05 M tris buffer according to a slight modification of the method of Kean and Roseman (17) . protein.
Tube
Following quantitation the thiobarbituric acid-reactive mate- -I a range of 0.6-3.9 nmol/protein.
As the above values could include not only free sialic acid but also CMP-sialic acid, the contribution of the latter compound was determined (see "Materials and Methods"). This showed that the CMP-sialic acid concentration in the patient's cells was within manner yielded similar material; however, at a much lower concentration (Fig. 1) .
Gas-liquid chromatography mass spectrometry analysis of the trimethyl silylated methyl derivative of the material isolated from the patient's cells by ion-exchange chromatography showed the same mass fragments that characterize standard N-acetylneuraminic acid (Fig. 2) .
As shown in Figure 3 addition of glucosamine to the culture medium of the patient's fibroblasts increased the already elevated intracellular free sialic acid levels to still higher values. Thus, when incubated for 72 h in 0.61 mM glucosamine (initial concentration) the free sialic acid concentration rose from an already abnormally high value of 74 to 137 nmol/mg protein (Fig. 3) . Initial extracellular levels of glucosamine above 0.61 mM had no additional effect on the measurable intracellular sialic acid pool(s) of the patient's cells.
In contrast to the sialuria cells, exposure of normal cells to increased concentrations of glucosamine yielded no detectable increase in their intracellular sialic acid concentration (Fig. 3) . Thus, in the presence of from 0 to 5 mM glucosamine for 72 h, normal cells maintained baseline levels of free sialic acid, i.e. 1 to 2 nmol/mg protein.
As shown in Figure 4 , however, addition of glucosamine to normal cells did result in an accumulation of the sialic acid precursor, UDP-N-acetylhexosamine. Thus, when incubated in media supplemented with an initial concentration of 0. Finally, addition of N-acetylmannosamine in place of glucosamine resulted in a marked accumulation of free sialic acid in both the normal cells and the patient's cells (Fig. 5) . As shown in Figure 5 culturing the cells in 20 mM N-acetylmannosamine (initial level) for 72 h increased the intracellular free sialic acid pool by 157 (from 95 to 252) nmol/mg protein in the patient's cells and by 120 (from 3 to 123) nmol/mg protein in the normal control cells.
DISCUSSION
The results presented herein demonstrate that cells from the original sialuria patient have 43.3 times more free sialic acid than normal cells, i.e. an average of 87 versus 2 nmol/mg protein. We conclude from this finding that these cultured fibroblasts express the fundamental biochemical defect responsible for the sialic acid abnormalities in sialuria.
The alterations in these cells could, in theory, arise from samine by sialic acid aldolase (1 9), absence of transfer of CMPsialic acid to glycoproteins and/or gangliosides by one or more sialyl transferases (20) or a defect in some, as yet, undiscovered catabolic pathway.
Alternatively, a maldistribution might result from a membrane defect causing either increased cellular or lysosomal storage similar to that found in cystinosis (2 1). A third hypothesis is that the sialic acid accumulation results, not from a metabolic or transport block, but rather from a disturbance in metabolic regulation. While inborn errors of metabolism due to overproduction appear to be rare, the magnitude and the types of the alterations in this patient suggest that this might be a likely possibility.
Investigations carried out over the past 20 yr indicate that sialic acid is produced by a wide spectrum of tissue types and sources via the pathway shown in Figure 6 (22, 23) . While incomplete, indirect evidence from both this and other laboratories suggest that cultured human cells may also produce sialic acid by a similar, if not identical, pathway. Direct proof, i.e. measurement of each enzyme step, is however lacking at this time. Several studies have shown that at least two steps of the pathway are subject to metabolic feedback regulation (24) in certain nonhuman tissues. Of possible relevance to this patient, both Kornfeld et al. (25) and Sommar and Ellis (26) have demonstrated in nonhuman tissues that CMP-sialic acid can regulate the biosynthesis of N-acetylmannosamine by feedback inhibition of UDP-N-acetylglucosamine 2-epimerase (see Fig. 6 ). More recently, we have obtained evidence that the conversion of UDP-N-acetylglucosamine to the next intermediate is also at least, a rate-limiting step in human skin fibroblasts (Thomas GH, Reynolds LW, Miller CS, unpublished data). Specifically, the addition of glucosamine to the medium of normal human cells causes a marked expansion of the intracellular level of UDP-N-acetylhexosamine while having no effect on the end product, free sialic acid (Thomas GH, Reynolds In contrast, as shown in Figures 3 and 4 , addition of glucosamine to the patient's fibroblasts results in a reduced accumulation of the metabolic intermediate, UDP-N-acetylhexosamine, and a marked expansion of the already elevated sialic acid pool. When the medium is enriched with N-acetylmannosamine in place of glucosamine both normal cells and the patient's cells accumulate free sialic acid; the increase was approximately the same (Fig. 5) .
These data indicate that the rate-limiting step in normal cells, i.e. conversion of UDP-N-acetylglucosamine to N-acetylmannosamine (Fig. 6) , is not rate limiting in the patient's cells. It is therefore concluded that the elevated level of free sialic acid in sialuria results from the overproduction of free sialic acid from one or more of its metabolic precursors. We speculate that this is due to hyperactivity or increased levels of UDP-acetylglucosamine 2-epimerase. This, however, is yet to be directly demonstrated.
Both Kamerling et al. (5) and more recently Cornfield and Schauer (24) have proposed that the basic defect in sialuria might be a lack of feedback regulation of UDP-acetylglucosamine 2-epimerase. As noted previously, the enzymatic conversion of UDP-N-acetylglucosamine to N-acetylmannosamine by this enzyme has been shown in various animal tissues to be regulated by cytidine monophosphate N-acetylneuraminic acid (25, 26) . It was thus proposed, that a defect in this regulation could result in overproduction of sialic acid and/or CMP-sialic acid in sialuria.
Cornfield and Schauer (24) also proposed a second possible explanation, namely a block in the second step of the UDPacetylglucosamine 2-epimerase reaction which might result in the formation of 2-acetamidoglucal. It is suggested that the 2-acetamidoglucal might then undergo nonenzymatic conversion to N-acetylglucosamine followed by catalysis of the latter compound to N-acetylmannosamine by a separate epimerase. If shown to be true this alternate pathway might bypass the regulated conversion of UDP-N-acetylglucosamine to N-acetylmannosamine thereby resulting in an overproduction of free sialic acid (24) .
Overproduction of sialic acid could, in theory, also result from defective CMP-N-acetylneuraminic acid synthetase activity. This would result in not only an accumulation of the substrate, free sialic acid, but also a lack of the product CMP-sialic acid. Absence of or decreased levels of CMP-sialic acid would, in turn, result in a depression of the metabolic "down regulation" of the 2-epimerase with a resulted increase in sialic acid production.
Studies are now underway to determine if the overproduction of sialic acid demonstrated herein is, in fact, due to one of the possibilities discussed above.
